title: Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience.
abstract: We have reclassified 110 patients with autoantibody-positive cryptogenic chronic hepatitis according tot he aggregate scoring system proposed by the International Autoimmune Hepatitis Group for signs of hepatitis C virus (HCV) infection and the newly proposed terminology of "unclassified" chronic hepatitis. Anti-HCV and HCV viremia were assessed by second-generation assays and reverse transcription-polymerase chain reaction. Immunomorphological and immunochemical characterizations of antinuclear, smooth, muscle, liver-kidney microsomal type 1, and liver cytosol type 1 autoantibodies were also performed. All 45 anti-HCV negative patients fulfilled the score criteria for the diagnosis of "definite" or "probable" autoimmune hepatitis (AIH). Eight anti-HCV-positive cases reached the score of "probable" AIH, whereas the remaining 57 cases were diagnosed as unclassified chronic hepatitis. The scoring system allows the correct identification of all autoimmune cases without HCV infection. Autoimmune hepatitis runs a more severe disease course than unclassified chronic hepatitis, whose clinical and histological features are similar to those of autoantibody-negative chronic hepatitis C.
authors.affiliation: Cattedra di Medicina Interna II, Istituto di Clinica Medica Generale e Terapia Medica, University of Bologna, Italy.
authors.forename: F B
authors.initials: FB
authors.lastname: Bianchi
authors.forename: F
authors.initials: F
authors.lastname: Cassani
authors.forename: M
authors.initials: M
authors.lastname: Lenzi
authors.forename: G
authors.initials: G
authors.lastname: Ballardini
authors.forename: L
authors.initials: L
authors.lastname: Muratori
authors.forename: F
authors.initials: F
authors.lastname: Giostra
authors.forename: D
authors.initials: D
authors.lastname: Zauli
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000974:Antibodies, Antinuclear / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D001327:Autoimmune Diseases / Q000150:complications / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006505:Hepatitis / Q000150:complications / Q000276:immunology*; D006526:Hepatitis C / Q000150:complications / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000276:immunology; D016133:Polymerase Chain Reaction; D012189:Retrospective Studies
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D018937:Hepatitis C Antibodies; C060729:anti-liver kidney microsome antibody